Author

Marc L. Peters-Golden

University of MichiganORCID 0000-0002-9768-0262Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1

Frequent Co-Authors

Jennifer M. SpethiD· 2 shared Sean M. FortieriD· 2 shared Carlos A. AguilariD· 1 shared Carol A. Feghali‐BostwickiD· 1 shared Christina DraijeriD· 1 shared Jared D. BaasiD· 1 shared John VargaiD· 1 shared Loka Raghu Kumar PenkeiD· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Jennifer M. SpethORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Longitudinal Single-Cell RNA-seq Profiling of Lung Cell Phenotypes, Signaling, and Cross-talk During Fibrosis Resolution

Jennifer M. Speth, Vivian T Wong, Steve D. Guzman, Yang Liu, Natalie Walker, Rachel L. Zemans, Timothy S. Blackwell, Carlos A. Aguilar, Marc L. Peters-Golden, Sean M. Fortier

The paper uses longitudinal single-cell RNA-seq to study lung fibrosis resolution, identifying pro- and anti-fibrotic pathways and cellular interactions during recovery.

bioRxiv · Apr 7, 2026 · PreprintCell Biology

Distinct cAMP regulation in scleroderma lung and skin myofibroblasts governs their dedifferentiation via p38α inhibition

Jared D. Baas, John Varga, Carol A. Feghali‐Bostwick, Marc L. Peters-Golden, Sean M. Fortier

This study compares cAMP regulation and dedifferentiation in lung and skin myofibroblasts from scleroderma patients, finding tissue-specific differences in PGE2 response and p38 inhibition effects.

The FASEB Journal · Jun 24, 2025Peer-reviewedMolecular Biology

Bortezomib inhibits lung fibrosis and fibroblast activation without proteasome inhibition

Loka Raghu Kumar Penke, Jennifer M. Speth, Scott Wettlaufer, Christina Draijer, Marc Peters-Golden

This study shows bortezomib reduces lung fibrosis and fibroblast activation without inhibiting proteasome activity.

American Journal of Respiratory Cell and Molecular Biology · Jul 8, 2021Peer-reviewedMolecular Biology